Mydx Research and Development Private Limited
About Mydx Research and Development Private Limited
Data last updated:
Mydx Research and Development Private Limited is a private limited company based in Delhi, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 12 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2021PTC388174.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nitin Arora and Nitin Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 123 1st Floor Vardhman Bahnhof Plaza Plot No. 10 Pocket – 7 Sec – 12 Dwarka, Delhi, India – 110078.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mydx Research and Development Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 123 1st Floor Vardhman Bahnhof Plaza Plot No. 10 Pocket – 7 Sec – 12 Dwarka, Delhi, India – 110078
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Mydx Research and Development Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mydx Research and Development Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Mydx Research and Development Private Limited, buy the company report.
Board of directors of Mydx Research and Development Private Limited
Mydx Research and Development has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Arora | Director | 25 Mar 2023 | 3 Years 7 Months | Current |
| Nitin Gupta Also directs: Genenest Biotech Private Limited, T and D Diagnostics India Private Limited, Biostate Consulting Private Limited and 1 more | Director | 12 Oct 2021 | 5 Years 0 Months | Current |
| Avinash Kumar Singh Also directs: Biodx Healthcare Private Limited, Genenest Biotech Private Limited, Easemytrade Private Limited and 1 more | Director | 12 Oct 2021 | 5 Years 0 Months | Current |
| Ashutosh Kumar Pandey Also directs: Navadvipa Naturals Agro Private Limited, Adjac India Private Limited, Janvaidya Biologicals Private Limited and 1 more | Director | 25 Mar 2023 | 3 Years 7 Months | Current |
Auditor
Mydx Research and Development Private Limited is audited by Pankaj Malik & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Pankaj Malik & Associates | FY 2023 | 031556N |
Shareholding
The shareholding of Mydx Research and Development Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mydx Research and Development Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mydx Research and Development Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mydx Research and Development Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mydx Research and Development Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
No GST registration is on our record for Mydx Research and Development Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mydx Research and Development Private Limited has 7 board changes on record since 2021: 4 appointments and 3 cessations. The latest: Ashutosh Kumar Pandey ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Mydx Research and Development is an active private limited company based in Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 12 October 2021 (5+ years old) and is registered under CIN U85100DL2021PTC388174.
Mydx Research and Development has 4 current directors:
- Nitin Arora - Director
- Nitin Gupta - Director
- Avinash Kumar Singh - Director
- Ashutosh Kumar Pandey - Director
The latest financial statements of Mydx Research and Development on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Mydx Research and Development is U85100DL2021PTC388174. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mydx Research and Development was incorporated on 12 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Ashutosh Kumar Pandey ceased to be Additional Director on 29 Sep 2023. Nitin Arora ceased to be Additional Director on 29 Sep 2023. Ashutosh Kumar Pandey was appointed as Director on 25 Mar 2023. Mydx Research and Development has 7 board changes on record in total.
The registered office of Mydx Research and Development is at Shop No. 123 1st Floor Vardhman Bahnhof Plaza Plot No. 10 Pocket – 7 Sec – 12 Dwarka, Delhi, India – 110078.
Mydx Research and Development operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of Mydx Research and Development is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.
Mydx Research and Development can be reached at its registered office: Shop No. 123 1st Floor Vardhman Bahnhof Plaza Plot No. 10 Pocket – 7 Sec – 12 Dwarka, Delhi, India – 110078.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
